In prostate cancer there are multiple contradictory reports regarding the role and expression of SSTR2 (for a summary see [6]): Hansson et al., for instance, suggest an up-regulation of SSTR2 expression in prostate cancers [7], Morichetti and coworkers found increased SSTR2 immunostaining in 80% of incidental prostate cancers [8]. The gene discussed is SSTR2; the disease is prostate cancer.